The European meeting in Adult Congenital Heart Disease, EuroGUCH, provides an independent educational forum for healthcare professionals across Europe.
It is aimed at cardiologists and allied medical professionals with an interest in congenital heart disease as well as specialists in the field.
Focus of the meeting is innovative treatments and interventions which can be applied to the adult patient population with congenital heart disease, with a faculty made up of internationally renowned speakers and experts in the field.
The Annual Meeting of the ESC Working Group on Adult Congenital Heart Disease (ACHD)
EuroGUCH 2021 was held online which will give another dimension to our event. This year, the programme will be organised into sessions, moving through the different stages and issues patients born with congenital heart disease face as they survive to adulthood.
You will be able to attend rapid-fire sessions, case-based symposia and debates to allow intense interaction between the audience and experts in various fields of congenital cardiology and also in-depth discussion of ongoing questions.
In this unusual year in which many scientific conferences have been cancelled or switched from face-to-face meetings to virtual meetings due to the coronavirus pandemic, we are very pleased to announce that the Working Group on Adult Congenital Heart Disease is planning to organise the virtual edition of the 12th Annual Congress, EUROGUCH 2021.
The meeting will cover the different stages and issues patients born with congenital heart disease face as they survive to adulthood. Initially, the challenges of the organisation of healthcare and diagnostic approach evolved to incorporate the most modern non-invasive diagnostic tools. Later, our adolescents and young adults, and with them, their physicians, faced the risk of arrhythmias, sudden cardiac death and thereupon re-interventions and its indications. And finally, as ACHD population ages, the management of co-morbidities and heart failure or advance care planning has to be an integral part of the comprehensive care for adults with congenital heart disease.
On behalf of the ESC Working Group on ACHD Nucleus and the Conference Scientific Committee